The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.

A significant shareholding is being unloaded to the public.

One pundit tracking the company is particularly concerned about the performance of its foundational snacks business.

Usually, the Federal Open Market Committee makes decisions on adjusting its federal funds rate in unison. But not this time.

UiPath has struggled this year as its growth rate has been slowing down and it's nowhere near posting a profit. The consensus ...

Nvidia has built a solid position for itself in this fast-growing data center niche that could help generate sizable revenue ...

Intel stock closed up 3.3% on the news, after jumping as much as 9.5% when the story first broke. Qualcomm closed down 2.9% ...

If management's predictions are accurate, the company is in for a period of sustained growth.

New York Community Bancorp isn't realistically poised for sudden and dramatic improvement. The bank expanded too quickly in ...

Those pressures do not appear to be easing. In its fiscal 2025 first quarter, which ended Aug. 31, FedEx earned $3.60 per ...

However, CEO Elon Musk prefers to blame a different culprit: Interest rates. Time and again, the Tesla chief has gone to ...

Say you've been holding off on signing or refinancing a mortgage because rates were stuck around 7%. Currently, the average ...